Jinyu Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jinyu Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Fan Rong
Shanghai Jiao Tong University
1 shared publication - Junsheng Chen
Shanghai Jiao Tong University
1 shared publication - Wei Li
Core Facility and Technical Service Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
1 shared publication - Yin Wang
Engineering Research Center of Cell & Therapeutic Antibody, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China
1 shared publication - Yujia Lu
Shanghai Jiao Tong University
1 shared publication - Yuxuan Ge
Shanghai Jiao Tong University
1 shared publication
Latest Publications
- Open Access
- 7 May 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Hydrogen sulfide-releasing nanocascade templated by glucose oxidase for diabetic infection treatment
Diabetic ulcer receives much attention in recent years due to its high incidence and mortality, promoting the scientific community to develop various strategies for such chronic disease treatments. However, the therapeutic outcome of these approaches is highly compromised by the invasive bacteria and severe inflammatory ulcer microenvironment. To overcome these dilemmas, microenvironment-responsive self-delivery GOx@MnS nanoparticles (NPs) are developed by a one-step biomineralization. When encountered with high glucose level in the ulcer site, GOx catalyze glucose to decrease the local pH and trigger the steady release of both manganese ions (Mn2+) and hydrogen sulfide (H2S). Mn2+ react with hydrogen peroxide to generate hydroxyl radical for the elimination of bacterial infection, meanwhile H2S is able to suppress the inflammatory response and accelerate diabetic wound healing through macrophage polarization. The excellent biocompatibility, strong bactericidal activity, and considerable immunomodulatory effect promise GOx@MnS NPs great therapeutic potential for diabetic wound treatment.
- 7 May 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessHydrogen sulfide-releasing nanocascade templated by glucose oxidase for diabetic infection treatment
Diabetic ulcer receives much attention in recent years due to its high incidence and mortality, promoting the scientific community to develop various strategies for such chronic disease treatments. However, the therapeutic outcome of these approaches is highly compromised by the invasive bacteria and severe inflammatory ulcer microenvironment. To overcome these dilemmas, microenvironment-responsive self-delivery GOx@MnS nanoparticles (NPs) are developed by a one-step biomineralization. When encountered with high glucose level in the ulcer site, GOx catalyze glucose to decrease the local pH and trigger the steady release of both manganese ions (Mn2+) and hydrogen sulfide (H2S). Mn2+ react with hydrogen peroxide to generate hydroxyl radical for the elimination of bacterial infection, meanwhile H2S is able to suppress the inflammatory response and accelerate diabetic wound healing through macrophage polarization. The excellent biocompatibility, strong bactericidal activity, and considerable immunomodulatory effect promise GOx@MnS NPs great therapeutic potential for diabetic wound treatment.